Graves’ 病不同治疗方法对患者生活质量的影响:一项系统综述和 Meta 分析
Effect of different therapeutic approaches on quality of life of patients with Graves’ disease: a systematic review and meta-analysis
一项系统综述和 Meta 分析评估了抗甲状腺药物、放射性碘和手术治疗 Graves’ 病后的生活质量。研究发现,手术治疗在抑郁和情绪敏感性方面优于放射性碘,而抗甲状腺药物在性生活方面优于放射性碘。所有治疗方法均改善了患者的生活质量,但不同治疗在特定领域的效果存在差异。
- Article
- Open access
- Published: 10 November 2026
- Shervin Mossavarali1 na1,
- Ali Vaezi1 na1,
- Dorsa Ghorban Sarvi1,
- Niloofar Mirdamadi1,
- Shahrzad Mohseni1 &
- …
- Mahnaz Pejman Sani ORCID: orcid.org/0000-0001-6708-17471,2
Scientific Reports (2026) Cite this article
We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.
Abstract
Graves’ disease (GD) impairs quality of life (QoL), and the effects of different treatments, including antithyroid drugs (ATD), radioiodine (RAI), and surgery, on QoL remain unclear. This study aimed to assess and compare QoL outcomes following these therapies. We conducted a PRISMA-based systematic review and meta-analysis, searching PubMed, Embase, Scopus, and Web of Science to July 30, 2025, for studies assessing QoL after GD treatment using generic SF-36 or thyroid-specific ThyPRO questionnaires. Mean scores were pooled using random-effects models. Sixteen studies were included. Among SF-36 domains, physical functioning had the highest scores for ATD (66.24 [43.97–88.50]) and RAI (84.02 [78.53–89.52]), while social functioning was highest after surgery (72.32 [55.62–89.01]). Vitality was among the lowest-scoring domains for ATD (55.90 [44.63–67.16]), RAI (59.35 [50.35–68.34]), and surgery (55.41 [47.10–63.71]), while bodily pain was lowest for surgery (51.11 [22.70–79.51]). In ThyPRO, tiredness was the worst-scoring domain for all treatments (ATD 40.04 [31.31–48.78]; surgery 32.50 [21.05–43.95]; RAI 41.90 [39.49–44.31]). The most favorable outcomes were observed for goiter symptoms after surgery (7.08 [0.42–13.74]) and RAI (12.03 [5.94–18.12]), and for sex life after ATD (11.59 [6.49–16.69]). Surgery showed significantly better QoL scores than RAI for depression and emotional susceptibility, while ATD was significantly better than RAI for sex life. All treatments were associated with improvements in QoL, with differences across specific domains. These findings may help clinicians and patients understand treatment-related QoL outcomes and support informed treatment decisions.
Abbreviations
- ATD:
-
Antithyroid drug
- CIs:
-
Confidence intervals
- GD:
-
Graves’ disease
- MeSH:
-
Medical subject headings
- PRISMA:
-
Preferred reporting items for systematic reviews and meta-analyses
- PROSPERO:
-
International prospective register of systematic reviews
- QoL:
-
Quality of life
- RAI:
-
Radioiodine
- SD:
-
Standard deviation
- SE:
-
Standard error
- SF-36:
-
36-Item short form health survey
- ThyPRO:
-
Thyroid-specific patient-reported outcome
Acknowledgements
None.
Funding
There was no funding.
Author information
Author notes
Shervin Mossavarali and Ali Vaezi contributed equally to this manuscript, and both should be considered the first authors.
Authors and Affiliations
Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
Shervin Mossavarali, Ali Vaezi, Dorsa Ghorban Sarvi, Niloofar Mirdamadi, Shahrzad Mohseni & Mahnaz Pejman Sani
Department of Endocrinology, Shariati Hospital, School of Medicine,, Tehran University of Medical Sciences, Tehran, Iran
Mahnaz Pejman Sani
Authors
- Shervin Mossavarali
- Ali Vaezi
- Dorsa Ghorban Sarvi
- Niloofar Mirdamadi
- Shahrzad Mohseni
- Mahnaz Pejman Sani
Corresponding author
Correspondence to Mahnaz Pejman Sani.
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics approval
The ethics committee of Endocrinology and Metabolism Research Institute reviewed and accepted the study protocol (ethical code: IR.TUMS.EMRI.REC.1404.078).
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Mossavarali, S., Vaezi, A., Ghorban Sarvi, D. et al. Effect of different therapeutic approaches on quality of life of patients with Graves’ disease: a systematic review and meta-analysis. Sci Rep (2026). https://doi.org/10.1038/s41598-026-78246-2
Received: 09 May 2026
Accepted: 26 October 2026
Published: 10 November 2026
DOI: https://doi.org/10.1038/s41598-026-78246-2
Keywords
来源:Nature 健康护理主题 · nature.com